Figure 5.
In vivo efficacy of NP KU55933 as a radiosensitizer for non-small cell lung cancer. Mice bearing flank tumor xenografts (A) H460 and (B) A549 were intravenous injected with NP KU55933, KU55933 and saline followed by radiation therapy (XRT). Tumors were irradiated in 3 daily fractions of 5 Gy followed by chemotherapy injection.